drug

TAK-101

Phase 2updated 3mo ago

by $TAK TAKEDA PHARMACEUTICAL CO LTD

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying TAK-101

phase2Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Dietcompletedn=102

News(1)

Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one
Takeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at treating the condition.
fiercebiotech · 15d ago

Data sources

ClinicalTrials.gov

last refreshed 35m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

TAK-101

Phase 2updated 3mo ago

by $TAK TAKEDA PHARMACEUTICAL CO LTD

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying TAK-101

phase2Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Dietcompletedn=102

News(1)

Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one
Takeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at treating the condition.
fiercebiotech · 15d ago

Data sources

ClinicalTrials.gov

last refreshed 35m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

TAK-101

all catalysts(0)

Trials studying TAK-101

News(1)

Report a data issue

comments(0)

TAK-101

all catalysts(0)

Trials studying TAK-101

News(1)

Report a data issue

comments(0)